-
We are pleased to announce that Health Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025 will take place on 12 June 2025 as the official pre-meeting of APACC 2025 in Tokyo, Japan.
-
Register to the Health Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025 here.
-
Registration is complimentary for Healthcare Professionals (HCPs), NGO Representatives, Advocates, Community Representatives, Policymakers/ Government Representatives. Healthcare professionals are defined as professionals that provide any type of health care service to people living with HIV/Hepatitis or other diseases.
-
Fees apply to representatives from industry, medical education providers, investment companies, and others not listed above.
-
To stay updated on the relevant developments, make sure you are signed up for our newsletter.
Health Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025
What's New
About this Program
Health Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025 offers an interactive platform that brings together patient community representatives, healthcare professionals, and health innovators to explore how digital technologies can transform care for people living with HIV (PLHIV). The goal is to foster open dialogue, promote shared decision-making, and address the stigma that remains a major barrier to effective HIV prevention, treatment, and care.
Participants will engage in discussions on the latest advancements in medical technologies—including mobile apps, telehealth, social media, and wearable devices—and examine practical strategies for integrating these tools into existing healthcare systems. By focusing on accessibility, anonymity, and personalization, these innovations offer a powerful means to educate, advocate, and support PLHIV while ensuring confidentiality and reducing fear of judgment.
This meeting emphasizes the role of technology in creating safe spaces, enhancing medication adherence, and enabling real-time support. It also highlights how digital platforms can extend public health messaging to at-risk communities and allies, promoting greater awareness, inclusivity, and health equity.
A key focus of the program is shared decision-making (SDM), which positions patients as active participants in their care. By combining clinical expertise with patients’ lived experiences and values, SDM ensures that treatment plans are not only evidence-based but also relevant and sustainable. This approach helps build trust, improve outcomes, and respect the autonomy of PLHIV.
Through dynamic discussions, real-world case studies, and collaborative knowledge exchange, the event aims to strengthen relationships among stakeholders and accelerate the adoption of innovative solutions in HIV and STI care. Ultimately, the Health Innovations to Reduce the Impact of Stigma in HIV/STI Care 2025 seeks to reduce stigma and discrimination, empower patients, and promote a healthcare environment that values dignity, equality, and partnership.
Program Chair
General Information
- Academic researchers;
- Community stakeholders;
- Medical technology companies and industry representatives;
- Policymakers.
1. Understand the Role of Innovations in Healthcare Transformation
- Explain how advancements in technology are reshaping healthcare delivery and access;
2. Analyze the Impact of Digital Tools on HIV Care
- Evaluate how digital platforms can raise awareness and thereby reduce HIV stigma and improve patient engagement;
3. Improve Competence in Shared Decision-Making Strategies
- Identify the principles of shared decision-making (SDM) and demonstrate its importance in fostering patient-clinician collaboration for personalized and effective care strategies;
4. Promote the Adoption of Innovations in Healthcare Settings
- Develop strategies to overcome barriers to implementing digital health technologies and advocate for their integration into routine clinical practice to improve health outcomes and equity.
Practical Information
The pre-meeting and main conference will take place in the Tokyo International Exchange Center - Plaza Heisei, Tokyo, Japan.
Address:
2 Chome-2-1 Aomi,
Koto City, Tokyo
135-0064, Japan
Distance from Haneda Airport Passenger Terminal: 15km
Distance from Narita International Airport: 70km
Distance from Tokyo International Cruise Terminal Station: 220m, about 3 mins walk
Please see here for details about visa: https://www.mofa.go.jp/j_info/visit/visa/index.html
Translation will not be provided.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE | AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Fees and Conditions
|
Regular Delegates* In-Person & Virtual |
Industry Delegates** In-Person |
Industry Delegates** Virtual |
|
|---|---|---|---|
|
Standard Registration Fee |
Complimentary |
€295 |
€195 |
*The following participants have a complimentry registration: Healthcare Professionals (HCPs), NGO Representatives, Advocates, Community Representatives, Policymakers/ Government Representatives. Healthcare professionals are defined as professionals that provide any type of health care service to people living with HIV/Hepatitis or other diseases.
**Fees apply to representatives from industry, medical education providers, investment companies, and others not listed above.
Important
-
We strongly advise that you register early to ensure your registration. Registration will close when the capacity of the venue is reached.
-
Submission of your online registration does not guarantee that your registration has been accepted. Your registration is final when full prepayment has been received and a confirmation of your registration has been sent.
- Access to all scientific sessions;
- Refreshments during the coffee breaks.
For virtual attendees only:
- Access to all scientific sessions
IMPORTANT:
- No day rate is available
- Payment can only be made by credit card.
- VE | AME reserves the right to cancel improper registrations. Claims for a refund will not be honored.
- Cancellation before/on 12 May 2025: 50% refund (minus an administration fee of €40)
- Cancellation after 12 May 2025: Unfortunately, no refund will be given
If you are unable to attend the conference, a substitute delegate is always welcome at no extra charge, provided that a letter of authorization from the original participant has been received and the conference secretariat has been notified of the name of the substitute delegate before 29 May 2025. A statement (email/letter) of cancellation must be sent to VE | AME.
1. Proof of accreditation
2. Valid identification (e.g. passport)
3. A letter from your assignment giver stating the details of your assignment (e.g. editor)
4. At least 3 previous written assignments in recognized outlets on HIV. If you are a freelance journalist, the assignments can be from different (recognizable) news outlets. Links to online publications are accepted
5. The website of the publication(s)/blog(s) that will be featuring your story on this workshop
A complimentary or reduced registration fee may apply for accredited media participants depending on availability. Preference will be given to credible print and online news sources. Please contact the conference secretariat for registration conditions.
We would like to receive a copy of your workshop report/ article once it is finalized.
All credentials will be verified by the Organizing Committee of the workshop. Media representatives are kindly requested to register by sending the above-mentioned information to info@amededu.com.
Important: Media is restricted to the written press. Recording on film or photo is not allowed. VE | AME will request a copy of the written piece once it is finalized. Media representatives must also agree to abide by the 2025 embargo policy.
Preliminary Program
Thursday, 12 June 2025
Health Innovations to Reduce The Impact of Stigma in HIV/STIC Care 2025 is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
